Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07210580 · ClinicalTrials.gov registry record · NA

Testing the Impact of Measurement-Based Care on Quality of Life and Disease Management Among Veterans With Inflammatory Bowel Disease

A NA study of Inflammatory Bowel Disease, sponsored by VA Office of Research and Development.

Recruiting
Registry status
NA
Development phase
250
Enrollment target
4
Study locations

NCT07210580 is a NA study of Inflammatory Bowel Disease that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 250 participants, below the 395-participant average among 28 other Inflammatory Bowel Disease trials with a reported enrollment target (37% lower). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07210580, a NA study of Inflammatory Bowel Disease, is actively recruiting participants, sponsored by VA Office of Research and Development.

RECRUITING
Registry status
NA
Development phase
250 participants
Enrollment target
4
Study locations

Study Summary

This research study is addressing issues related to Inflammatory bowel disease (IBD), which is a chronic autoimmune disorder that affects over 60,000 Veterans. With close monitoring and timely treatment adjustment, the investigators can stop the natural progression of IBD, improving health-related quality of life (HRQOL) and reducing flares and hospitalizations. However, it is difficult to closely monitor Veterans with IBD between clinic visits. There is a critical need for solutions that support close between visit monitoring of Veterans with IBD. The Measurement-Based Care (MBC) for IBD study will take a systematic approach to collect, share, and act on patient reported outcome (PRO) data that can be used to achieve close monitoring. MBC supports patients' in managing their condition and boosting their confidence in their ability to handle their symptoms and disease, and also supports care teams in early recognition of health issues. The investigators will work with both Veterans and their care teams to understand and assess this program so it can be a model for future initiatives.

Conditions Studied

Inflammatory Bowel Disease

Interventions

  • BEHAVIORAL MBC-IBD Intervention
  • OTHER Enhanced Treatment as Usual (E-TAU)

Study Locations (4)

Georgia

  • Atlanta VA Medical and Rehab Center, Decatur, GA - Decatur

Michigan

  • VA Ann Arbor Healthcare System, Ann Arbor, MI - Ann Arbor

Oregon

  • VA Portland Health Care System, Portland, OR - Portland

Texas

  • Michael E. DeBakey VA Medical Center, Houston, TX - Houston

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2026-03-09
Est. Completion 2029-09-30
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07210580

The ClinicalTrials.gov registry entry for NCT07210580 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 395-participant average among 28 other Inflammatory Bowel Disease trials with a reported enrollment target (37% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Inflammatory Bowel Disease appearing as the primary indexed condition, and to 2 interventions - of which MBC-IBD Intervention is the first listed.

NCT07210580 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Georgia, Michigan, Oregon.

Frequently Asked Questions

What is clinical trial NCT07210580 about?

NCT07210580 is a clinical study titled "Testing the Impact of Measurement-Based Care on Quality of Life and Disease Management Among Veterans With Inflammatory Bowel Disease". This research study is addressing issues related to Inflammatory bowel disease (IBD), which is a chronic autoimmune disorder that affects over 60,000 Veterans. With close monitoring and timely treatment adjustment, the investigators can stop the natural progression of IBD, improving health-related q...

What is the current status of trial NCT07210580?

This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2026-03-09. Estimated completion is 2029-09-30.

What conditions does trial NCT07210580 study?

This clinical trial studies the following conditions: Inflammatory Bowel Disease.

What interventions are being tested in trial NCT07210580?

The interventions under investigation include: MBC-IBD Intervention (BEHAVIORAL), Enhanced Treatment as Usual (E-TAU) (OTHER).

Who is sponsoring clinical trial NCT07210580?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07210580 being conducted?

This trial has 4 study locations across Georgia, Michigan, Oregon, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Inflammatory Bowel Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Inflammatory Bowel Disease

All registered trials for this condition

Georgia

All trials with a study site in Georgia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.